Gilead Sciences
Trade Gilead Sciences 24 hours a day, five days a week on Robinhood.
Robinhood gives you the tools to revolutionize your trading experience. Use the streamlined mobile app, or access advanced charts and execute precise trades on our browser-based platform, Robinhood Legend. Risks and limitations apply.About GILD
Gilead Sciences, Inc. is a biopharmaceutical company, which engages in the research, development, and commercialization of medicines in areas of unmet medical need. The firm's primary areas of focus include human immunodeficiency virus, acquired immunodeficiency syndrome, liver diseases, hematology, oncology, and inflammation and respiratory diseases.
GILD Key Statistics
Stock Snapshot
Gilead Sciences(GILD) stock is priced at $169.52, giving the company a market capitalization of 210.26B. It carries a P/E multiple of -53.91 and pays a dividend yield of 1.91%.
During the trading session on 2026-11-12, Gilead Sciences(GILD) shares reached a daily high of $171.70 and a low of $169.00. At a current price of $169.52, the stock is +0.3% higher than the low and still -1.3% under the high.
Trading activity shows a volume of 686.76K, compared to an average daily volume of 7.63M.
The stock's 52-week range extends from a low of $116.88 to a high of $176.58.
The stock's 52-week range extends from a low of $116.88 to a high of $176.58.
GILD News
Argus raised the firm’s price target on Gilead (GILD) to $190 from $165 and keeps a Buy rating on the shares. The stock has risen to new all-time highs followi...
Gilead (GILD) Sciences announced a new collaboration with TelevisaUnivision and the 27th Latin GRAMMY Awards that will bring HIV prevention awareness into one o...
...
Analyst ratings
77%
of 30 ratingsMore GILD News
The next wave of U.S. drug-price negotiations could put billions of dollars in pharmaceutical revenue under pressure, with Eli Lilly and Co (NYSE:LLY), Gilead S...
Gilead Sciences (GILD) is back in focus after PURPOSE 5 data showed higher one year PrEP persistence for twice yearly lenacapavir injections compared with daily...
Gilead Sciences Inc. (NASDAQ:GILD) announced positive clinical updates across its portfolio, highlighting key trial data for its twice-yearly HIV prevention inj...
Biotech stocks have performed well in 2026, but things could change fairly rapidly. The industry is notoriously volatile, after all, and there are significant r...
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.